论文部分内容阅读
近年来对剖宫产瘢痕妊娠(CSP)的报道逐渐增多,也随之出现了各种不同的治疗方法,但在全球范围内仍无统一的治疗方案。药物治疗主要为甲氨蝶呤(MTX)的全身、局部及联合用药;介入治疗大大降低了常规治疗切除子宫的风险,是目前CSP患者大出血的首选止血措施;手术治疗主要包括清宫术、多种途径病灶切除的保守性手术及子宫切除术。虽然CSP的治疗方法已达31种之多,但仍然处于小样本研究,治疗方案的选择应遵循适合个体病情特点的个体化治疗原则。
In recent years, reports of cesarean scar pregnancy (CSP) have been gradually increasing, and various treatment methods have emerged. However, there is no unified treatment plan worldwide. Drug treatment is mainly methotrexate (MTX) systemic, topical and combination therapy; Interventional therapy greatly reduces the risk of conventional treatment of uterine incision, is the first choice of hemostasis in patients with CSP hemostasis; surgical treatment including curettage, a variety of Conservative surgery and hysterectomy via focal excision. Although CSP has reached as many as 31 kinds of treatment methods, but still in a small sample study, the choice of treatment options should be based on the individual characteristics of the individual treatment principles.